Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
Brad H. Rovin(The Ohio State University Wexner Medical Center), Jürgen Floege(RWTH Aachen University), Pierre Ronco(Inserm), Jack F.M. Wetzels(Radboud University Nijmegen), Elizabeth M. Rave, David J. Tunnicliffe(The University of Sydney), Marcello Tonelli(University of Calgary), Vivekanand Jha(The George Institute for Global Health), Jonathan C. Craig(Flinders University), Adrian Liew, Carla Nester(University of Iowa), Michael Cheung(National Kidney Foundation), Jonathan Barratt(University of Leicester), Heather N. Reich(University Health Network), Amy Earley, Sharon G. Adler(UCLA Medical Center), Jan‐Stephan Sanders(Tufts University), Marina Vivarelli(Bambino Gesù Children's Hospital), Tak Mao Chan(Chinese University of Hong Kong), David Jayne(University of Cambridge), Sanjeev Sethi(Mayo Clinic), Kelly A. Burdge, Fernando C. Fervenza(Mayo Clinic), Yusuke Suzuki(Juntendo University), Vladimı́r Tesař(Charles University), Martin Howell(UNSW Sydney), Richard J. Glassock(University of California, Los Angeles), Jai Radhakrishnan(Columbia University), Frank Bridoux(Université de Poitiers), Sydney Tang(Chinese University of Hong Kong), Lyubov Lytvyn(Impact), Keisha L. Gibson(University of North Carolina at Chapel Hill), H. Terence Cook(National Health Service), Juan M. Mejía‐Vilet(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán)
Cited by 809
Related Papers
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|Arthritis & Rheumatism|2012|6.6k
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
|Autophagy|2016|6k
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Worldwide access to treatment for end-stage kidney disease: a systematic review
|The Lancet|2015|2.3k
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
|New England Journal of Medicine|2010|1.7k